Detalhe da pesquisa
1.
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study.
J Antimicrob Chemother
; 77(7): 1996-2002, 2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403189
2.
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study.
J Antimicrob Chemother
; 75(3): 618-627, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31828337
3.
Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection.
J Clin Med
; 10(1)2020 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33374989
4.
Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.
Antimicrob Agents Chemother
; 50(4): 1251-6, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16569836
5.
Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
J Antimicrob Chemother
; 58(1): 95-100, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16636085